154 related articles for article (PubMed ID: 11923219)
41. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
42. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
43. Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
Bandyopadhyay A; López-Casillas F; Malik SN; Montiel JL; Mendoza V; Yang J; Sun LZ
Cancer Res; 2002 Aug; 62(16):4690-5. PubMed ID: 12183427
[TBL] [Abstract][Full Text] [Related]
44. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
45. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
[TBL] [Abstract][Full Text] [Related]
46. Interferon-β efficiently inhibited endothelial progenitor cell-induced tumor angiogenesis.
Xiao HB; Zhou WY; Chen XF; Mei J; Lv ZW; Ding FB; Li GQ; Zhong H; Bao CR
Gene Ther; 2012 Oct; 19(10):1030-4. PubMed ID: 22071966
[TBL] [Abstract][Full Text] [Related]
47. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
[TBL] [Abstract][Full Text] [Related]
48. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.
Baek SJ; Kim KS; Nixon JB; Wilson LC; Eling TE
Mol Pharmacol; 2001 Apr; 59(4):901-8. PubMed ID: 11259636
[TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
[TBL] [Abstract][Full Text] [Related]
50. Regulation of TGFbeta1-mediated growth inhibition and apoptosis by RUNX2 isoforms in endothelial cells.
Sun L; Vitolo MI; Qiao M; Anglin IE; Passaniti A
Oncogene; 2004 Jun; 23(27):4722-34. PubMed ID: 15107836
[TBL] [Abstract][Full Text] [Related]
51. Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells.
Yamanegi K; Kawabe M; Futani H; Nishiura H; Yamada N; Kato-Kogoe N; Kishimoto H; Yoshiya S; Nakasho K
Int J Oncol; 2015 May; 46(5):1994-2002. PubMed ID: 25778932
[TBL] [Abstract][Full Text] [Related]
52. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
53. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
[TBL] [Abstract][Full Text] [Related]
54. Advancement in the research on vascular endothelial growth inhibitor (VEGI).
Duan L; Yang G; Zhang R; Feng L; Xu C
Target Oncol; 2012 Mar; 7(1):87-90. PubMed ID: 22388993
[TBL] [Abstract][Full Text] [Related]
55. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.
Kumanishi S; Yamanegi K; Nishiura H; Fujihara Y; Kobayashi K; Nakasho K; Futani H; Yoshiya S
Int J Oncol; 2019 Jul; 55(1):167-178. PubMed ID: 31180533
[TBL] [Abstract][Full Text] [Related]
57. Vascular endothelial growth inhibitor in human cancer (Review).
Zhang N; Sanders AJ; Ye L; Jiang WG
Int J Mol Med; 2009 Jul; 24(1):3-8. PubMed ID: 19513527
[TBL] [Abstract][Full Text] [Related]
58. The differential expression of vascular endothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in human clear-cell renal cell carcinoma.
Zhang N; Wu P; Wu L; Shayiremu D; Shan H; Ye L; Jiang WG; Gong K; Yang Y
Cancer Genomics Proteomics; 2013; 10(1):47-53. PubMed ID: 23382586
[TBL] [Abstract][Full Text] [Related]
59. The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation.
Tian F; Grimaldo S; Fujita M; Cutts J; Vujanovic NL; Li LY
J Immunol; 2007 Sep; 179(6):3742-51. PubMed ID: 17785811
[TBL] [Abstract][Full Text] [Related]
60. MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis.
Levenson AS; Thurn KE; Simons LA; Veliceasa D; Jarrett J; Osipo C; Jordan VC; Volpert OV; Satcher RL; Gartenhaus RB
Cancer Res; 2005 Dec; 65(23):10651-6. PubMed ID: 16322206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
